Share This Article:

Effects of family history and consanguinity in primary immunodeficiency diseases in children in Qatar

Abstract Full-Text HTML Download Download as PDF (Size:488KB) PP. 47-53
DOI: 10.4236/oji.2013.32008    4,925 Downloads   8,311 Views   Citations

ABSTRACT

Background: The high consanguinity in Middle East increases the risk of genetic diseases, including primary immunodeficiency diseases (PID). Objectives: This study was aimed at determining the rate of positive family history of PID, the overall rate and type of consanguinity, and their effects on delay age during diagnosis of PID. Materials and methods: A retrospective analysis was conducted on 131 children with PID (aged 0 - 14 years) managed at Hamad General Hospital during 1998-2012. Results: Data on 131 patients (75 males & 56 females) of 82 families was analyzed. The most common phenotype of PID was predominantly antibody deficiency (23.7%). The onset age was 24.01 months and delay age 18.7 months. Family history of PID was 66.4% (38.7% in predominantly antibody deficiency and 100% in diseases of immune dysregulation). Positive family history significantly (p = 0.004) reduced the delay age of PID diagnosis by 52.9%. The consanguinity rate was 61.1% (32.3% in the predominantly antibody ID to 96% in the phagocyte defects group), where paternal cousin ranked the highest type (57.5%). Conclusions: This study indicates that family history is common in children with PID and helpful in reducing the delay age. Consanguinity among families of affected children is also high (higher than healthy population). Paternal parallel cousin marriages are the most common type of consanguinity. For a practicing physician, family history is a simple and useful tool

when suspecting PID in children. Primary prevention of PID in Middle East communities should consider consanguinity reduction through public awareness and education and premarital counseling programs.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Ehlayel, M. , Bener, A. and Laban, M. (2013) Effects of family history and consanguinity in primary immunodeficiency diseases in children in Qatar. Open Journal of Immunology, 3, 47-53. doi: 10.4236/oji.2013.32008.

References

[1] Rezaei, N., Bonilla, F.A., Sullivan, K.E., et al. (2008) An introduction to primary immunodeficiency diseases. In: Rezaei, N., Aghamohammadi, A. and Not-arangelo, L.D., Eds., Primary Immunodeficiency Diseases, Springer-Verlag, Berlin Heidelberg, 1-38.
[2] http://www.esid.org/clinical-diagnostic-criteria-for-pid-73-0
[3] Al-Herz, W., Bousfiha, A., Casanova, J.L., et al. (2011) Primary immunodeficiency diseases: An update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Frontiers in Immunology, 2, 54.
[4] Puck, J.M. and Nussbaum, R.L. (2007) Genetic principles and technologies in the study of Immune disorders. In: Ochs, H.D., Smith, C.I.E. and Puck, J.M., Eds., Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, Oxford University Press, New York, 16-26.
[5] Bener, A. (2012) Consanguineous marriages and their effect on common diseases in the Qatari population. Genetic Disorders in the Arab World, Qatar 2012, 4, 30-39. http://www.cags.org.ae/publications.html
[6] Ben-Omran, T. and Abdul W.A. (2012) Genetic disorders in Arab populations: Qatar. Genetic Disorders in the Arab World, Qatar, 4, 60-65. http://www.cags.org.ae/publications.html
[7] Tadmouri, G.O., Nair, P., Tasneem, O., Mahmound, T.A.A., et al. (2009) Consanguinity and reproductive health among Arabs. Reprod Health, 6, 17. doi:10.1186/1742-4755-6-17
[8] Islam, M.M. (2012) The practice of consanguineous marriage in oman: Prevalence, trends and determinants. Journal of Biosocial Science, 44, 571-594. doi:10.1017/S0021932012000016
[9] Suliaman, F., Al-Ghonaium, A. and Harfi, H. (2006) High incidence of severe combined immune deficiency in the eastern province of Saudi Arabia. Pediatric Asthma, Allergy & Immunology, 19, 14-18. doi:10.1089/pai.2006.19.14
[10] Reda, S.M., Afifi, H.M. and Amine, M.M. (2008) Primary imm unodeficiency diseases in Egyptian children: A single-center study. Journal of Clinical Immunology, 29, 343-351. doi:10.1007/s10875-008-9260-x
[11] Rezaei, N., Pourpak, Z., Aghamohammadi, A., et al. (2006) Consanguinity in primary immunodeficiency disorders, the report from Iranian primary immunodeficiency registry. American Journal of Reproductive Immunology, 56, 145-151. doi:10.1111/j.1600-0897.2006.00409.x
[12] Al-Herz, W., Naguib, K.K., Notarangelo, L.D. et al. (2011) Parental consanguinity and the risk of primary immunodeficiency disorders: Report from the Kuwait national primary immunodeficiency disorders registry. Internatinal Archieves of Allergy and Immunology, 154, 76-80. doi:10.1159/000319212
[13] Barbouche, M.R., Galal, N., Ben-Mustapha, I., et al. (2011) Primary immunodeficiencies in highly consanguineous North African populations. Annals of the New York Academy of Sciences, 1238, 42-52. doi:10.1111/j.1749-6632.2011.06260.x
[14] Al-Tamemi, S., Ibtisam, E. and Dennison, D. (2012) Primary immunodeficiency diseases in Oman: Five years’ experience at Sultan Qaboos University Hospital. World Allergy Organiz Journal, 5, 52-56. doi:10.1097/WOX.0b013e318258830f
[15] Azarsiz, E., Gulez, N., Edeer Karaca, N., et al. (2011) Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiencies: A single-center study. Journal of Clinical Immunology, 31, 106-111. doi:10.1007/s10875-010-9472-8
[16] Al-Herz, W. (2008) Primary immunodeficiency disorders in Kuwait: First report from Kuwait national primary immunodeficiency registry (2004-2006). Journal of Clinical Immunology, 28, 186-193. doi:10.1007/s10875-007-9144-5
[17] Naidoo, R., Ungerer, L., Cooper, M., et al. (2011) Primary immunodeficiencies: A 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. Journal of Clinical Immunology, 31, 99-105. doi:10.1007/s10875-010-9465-7
[18] Verma, S., Sharma, P.K., Sivanandan, S., et al. (2008) Spectrum of primary immune deficiency at a tertiary care hospital. The Indian Journal of Pediatrics, 75, 143-148. doi:10.1007/s12098-008-0022-9
[19] CEREDIH: The French PID Study Group. (2010) The French national registry of primary immunodeficiency diseases. Clinical Immunology, 135, 264-272. doi:10.1016/j.clim.2010.02.021
[20] http://www.esid.org/esid_registry.php
[21] Jeffrey Modell Foundation. (2009) 10 warning signs of primary immunodeficiency in children. www.info4pi.org/aboutPI/pdf/General10WarningSignsFINAL.pdf
[22] Khalilzadeh, S., Boloorsaz, M.R., Baghaie, N., et al. (2011) Primary immunodeficiency in children: Report of seven years study. TANAFFOS: Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, 10, 38-43.
[23] Golan, H., Dalal, I., Garty, B.Z., et al. (2002) The incidence of primary immunodeficiency syndromes in Israel. The Israel Medical Association Journal, 11, 868-871.
[24] Joshi, A.Y., Iyer, V.V., Hagan, J.B., St. Sauver, J.L. and Boyce, T.G. (2009) Incidence and temporal trends of primary immunodeficiency: A population-based cohort study. Mayo Clinic Proceedings, 84, 16-22. doi:10.4065/84.1.16
[25] Al-Herz, W. and Moussa, M.A. (2012) Survival and predictors of death among primary immunodeficient patients: A registry-based study. Journal of Clinical Immunology, 32, 467-473.
[26] Bener, A., Hussain, R. and Teebi, A.S. (2007) Consanguineous marriages and their effects on common adult diseases: Studies from an endogamous population. Medical Principles and Practice Journal, 16, 262-267.
[27] Koc I. (2008) Prevalence and sociodemographic correlates of consanguineous marriages in Turkey. Journal of Biosocial Science, 40, 137-148.
[28] Radovanovic, Z., Shah, N. and Behbehani, J. (1999) Prevalence and social correlates of consanguinity in Kuwait. Annals of Saudi Medicine, 19, 206-210.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.